AVE-0950

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameAVE-0950

Drug Alias NameAVE-0950

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSpleen tyrosine kinase inhibitors

TargetsSpleen tyrosine kinase

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi Aventis

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A